$1.40-0.08 (-5.41%)
Check-Cap Ltd., a clinical stage medical diagnostics company, focuses on capsule-based screening technology products.
Check-Cap Ltd. in the Healthcare sector is trading at $1.40 with a market capitalization of $12M. The stock is currently 64% below its 52-week high of $3.92, remaining 15.7% below its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the distress zone. Risk note: RSI 30 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 45/100 suggests a balanced risk-reward profile.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Check-Cap Ltd., a clinical stage medical diagnostics company, focuses on capsule-based screening technology products. Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.